Related Experiment Video
Updated: May 13, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Diagnostic biomarkers of diabetic nephropathy
Hideyuki Ito1, Hiroki Fujita, Takamune Takahashi
1Vanderbilt University Medical Center, Division of Nephrology and Hypertension, S-3223, MCN, Nashville, TN 37232, USA +1 615 343 4312 ; +1 615 343 7156 ; takamune.takahashi@vanderbilt.edu.
Abstract:
Clinical management and therapeutic intervention from the earlier stage of diabetic nephropathy (DN) is of major importance to prevent the progression of DN to end stage renal disease. At present, the measurement of albuminuria is used as a standardized non-invasive test for the diagnosis of early DN. Diabetic kidney disease, however, is not detected by this test in some cases. Hence, efforts have been made to find better diagnostic biomarkers of DN. These investigations have identified several proteins that can be used as diagnostic biomarkers of DN, including urinary immunoglobulin G, transferrin, ceruloplasmin and serum cystatin-C. Further, recent proteomics approaches have isolated potential biomarkers of DN. This review summarizes the diagnostic biomarkers developed over the last decade, and comments on their impacts in the diagnosis and management of this disease.
Related Concept Videos
Diabetic Nephropathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Retinopathy
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Diabetic Neuropathy
Diabetes: Symptoms, Diagnosis, and Complications
